Stockscreener 앱 받기
96.40
0.52%
-0.50
시간 외 거래:
96.40
Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스
MIRM (NASDAQ: MIRM) files Rule 144: 2,000 shares via option exercise - Stock Titan
Is It Too Late To Consider Mirum Pharmaceuticals (MIRM) After Its Strong Multi‑Year Share Price Run? - Yahoo Finance
Mirum Pharmaceuticals reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
ETF Watch: What are analysts price targets for Mirum Pharmaceuticals IncMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Aug Movers: Does Mirum Pharmaceuticals Inc stock benefit from AI growthMarket Activity Summary & Stepwise Trade Signal Guides - baoquankhu1.vn
Prediction: Buying This Biotech Stock Today Could Set You Up for Life - Yahoo Finance
Cantor Fitzgerald Sticks to Their Buy Rating for Mirum Pharmaceuticals (MIRM) - The Globe and Mail
How Mirum Pharmaceuticals Inc. (MIRM) Affects Rotational Strategy Timing - Stock Traders Daily
Cantor Fitzgerald reiterates Mirum Pharmaceuticals stock rating By Investing.com - Investing.com Canada
Bluejay Therapeutics 2025 Financials: Mirum Pharmaceuticals Merger, Liquidity, and Key Financial Statements - Minichart
Mirum (MIRM) details Bluejay deal and $268.5M PIPE financing - Stock Titan
Primary Sclerosing Cholangitis Market is expected to Hit US$ - openPR.com
18,710 Shares in Mirum Pharmaceuticals, Inc. $MIRM Purchased by SG Americas Securities LLC - MarketBeat
Mirum Pharmaceuticals, Inc. (MIRM) Surpasses Q3 Earnings and Revenue Estimates - MSN
Mirum (MIRM) Q1 2025 Earnings Call Transcript - AOL.com
MIRM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MIRM PE Ratio & Valuation, Is MIRM Overvalued - Intellectia AI
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Mirum Pharmaceuticals, Inc. (MIRM) stock price, news, quote and history - Yahoo Finance UK
Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report? - Eastern Progress
Mirum Pharmaceuticals, Inc. (MIRM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Mirum Pharmaceuticals (MIRM) Moves 5.1% Higher: Will This Strength Last? - qz.com
Mirum Pharmaceuticals (MIRM) Rises 5.1%: Can This Upward Momentum Continue? - Bitget
Mirum Pharma (MIRM) Earnings Call Transcript - The Globe and Mail
JPMorgan Chase & Co. Sells 380,067 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
(MIRM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
US Stocks Recap: Will Mirum Pharmaceuticals Inc stock hit new highs in YEARWeekly Profit Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Does Mirum Pharmaceuticals Inc stock benefit from AI growth2026 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
A Look At Mirum Pharmaceuticals (MIRM) Valuation After Strong Long Term Share Performance - Yahoo Finance
Hennion & Walsh Asset Management Inc. Sells 17,560 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Tudor Investment Corp ET AL Makes New $2.03 Million Investment in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals Stock: Pipeline Progress and Rare Disease Focus for Long-Term Investor Value - AD HOC NEWS
Energy Moves: Will Mirum Pharmaceuticals Inc benefit from AI trendsWeekly Market Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Mirum Pharmaceuticals (MIRM) and NovoCure (NVCR) - The Globe and Mail
Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $125.00 - MarketBeat
Vanguard disaggregates holdings; Mirum (MIRM) shows 0 shares owned - stocktitan.net
Mirum Pharmaceuticals Insiders Sell US$1.6m Of Stock, Possibly Signalling Caution - 富途牛牛
TD Cowen raises Mirum Pharmaceuticals stock price target to $125 - Investing.com
TD Cowen Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $125 - Moomoo
Citizens reiterates Mirum Pharmaceuticals stock rating on HDV data By Investing.com - Investing.com Canada
Citizens reiterates Mirum Pharmaceuticals stock rating on HDV data - Investing.com
Investor Mood: What are analysts price targets for Mirum Pharmaceuticals Inc2026 Institutional Moves & High Accuracy Trade Alerts - baoquankhu1.vn
Mirum completes enrollment & screening in liver disease studies - MSN
Citizens reiterates Mirum Pharmaceuticals stock rating ahead of data By Investing.com - Investing.com Canada
Citizens reiterates Mirum Pharmaceuticals stock rating ahead of data - Investing.com
Mirum Pharmaceuticals (NASDAQ:MIRM) Receives Buy Rating from HC Wainwright - marketbeat.com
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - MSN
Is Mirum Pharmaceuticals (NASDAQ:MIRM) Stabilizing After Rating Updates? - Kalkine Media
Mirum Pharmaceuticals (MIRM) completes enrollment for phase 3 EXPAND study of LIVMARLI - MSN
Baird updates Mirum Pharmaceuticals (MIRM) valuation following beat-and-raise earnings results - MSN
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - The Motley Fool
Mirum Pharmaceuticals (MIRM) Completes Enrollment for Phase 3 EXPAND Study of LIVMARLI - Insider Monkey
Responsive Playbooks and the MIRM Inflection - Stock Traders Daily
MIRM SEC FilingsMirum Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan
5 Most Promising Stocks Under $100 to Buy - Insider Monkey
RBC Capital initiates coverage of Mirum Pharmaceuticals (MIRM) with outperform recommendation - MSN
Why Mirum Pharmaceuticals Stock Is Sinking Today - TipRanks
2.69%
0.25%
자본화:
|
볼륨(24시간):